PREDILIFE Logo

PREDILIFE

ALPRE | PA

Overview

Corporate Details

ISIN(s):
FR0010169920 (+5 more)
LEI:
9695006IK5NBKHQU9116
Country:
France
Address:
39 RUE CAMILLE DESMOULINS, 94800 VILLEJUIF
Sector:
Health Care
Industry:
Biotechnology

Description

Pioneers of predictive medicine in France, we position ourselves as a player in 6P medicine: Predictive, Preventive, Personalized, Participative, Relevant, Multi-professional. After 14 years of research and development, Predilife obtained its medical device certification and began marketing predictive assessments: predictive breast cancer assessment, multi-pathology predictive assessments. At Predilife, we are passionate about serving health, a committed team that works every day to change the rules so that our motto "predict to prevent" is adopted by the greatest number of people. We accompany companies, healthcare professionals and employees towards the medicine of tomorrow: predictive, personalized and digital. We are working to make predictive medicine accessible to everyone in order to reduce the number of serious diseases. We believe that predictive medicine will enable effective prevention and thus reduce the risk of serious diseases.

Social Media

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-15 08:00
Inside Information Statement
RÉSULTATS ANNUELS 2024 - PERSPECTIVES DE CROISSANCE ET DE PARTENARIAT 2025
French 283.1 KB
2025-04-30 18:30
Earnings Release
REPORT DE LA PUBLICATION DES RESULTATS ANNUELS 2024 ET DU RAPPORT FINANCIER ANN…
French 162.4 KB
2025-01-17 18:00
Capital/Financing Update
Bilan semestriel au 31/12/2024 du contrat de liquidité PREDILIFE
French 417.3 KB
2025-01-08 18:30
Earnings Release
PREDILIFE DOUBLE SON VOLUME DE VENTE EN 2024 ET ANTICIPE UNE FORTE CROISSANCE P…
French 248.6 KB
2024-12-17 20:00
Regulatory News Service
PREDILIFE ANNONCE LA RÉALISATION D'UNE LEVÉE DE FONDS DE 779 000 EUROS DANS LE …
French 396.7 KB
2024-11-12 08:30
Capital/Financing Update
Predilife lance une émission d'obligations de 2M EUR à un taux de 8,5% par an s…
French 898.9 KB
2024-11-07 18:30
Regulatory News Service
Réalisation de l'apport partiel d'actif de MammoRisk à une valorisation de 202 …
French 225.6 KB
2024-10-30 19:00
Regulatory News Service
Predilife met à disposition son rapport financier semestriel 2024
French 158.4 KB
2024-10-28 08:30
Earnings Release
Résultats semestriels 2024 - Perspectives de croissance 2024
French 256.4 KB
2024-10-21 18:30
Regulatory News Service
Le Groupe Rocher prend une initiative majeure pour la santé des femmes et propo…
French 236.4 KB
2024-10-02 20:30
Regulatory News Service
Signature du traité d'apport partiel d'actif relatif à la filialisation de Mamm…
French 707.6 KB
2024-07-19 18:00
Capital/Financing Update
Bilan semestriel au 30/06/2024 du contrat de liquidité PREDILIFE
French 797.7 KB
2024-07-12 19:15
Capital/Financing Update
PREDILIFE annonce la réalisation d'une levée de fonds de 775 k EUR dans le cadr…
French 531.5 KB
2024-06-04 18:45
Capital/Financing Update
PREDILIFE LANCE UNE ÉMISSION D'OBLIGATIONS CONVERTIBLES DE 2M EUR A UN TAUX DE …
French 1.3 MB
2024-05-29 18:30
Regulatory News Service
PREDILIFE STRENGTHENS ITS ASSETS WITH THE ISSUANCE OF A PATENT FOR ITS AI METHOD
English 219.8 KB

Insider Transactions

Date Insider Name Position Type Shares Value
2024-07-30 N/A Other Buy 200 960.00 EUR
2024-07-04 N/A Other Buy 400 2,720.00 EUR
2024-06-26 N/A Other Buy 2,000 12,000.00 EUR
2024-06-18 N/A Other Buy 500 2,800.00 EUR
2024-05-02 N/A Other Sell 8,500 204,000.00 EUR
2024-04-26 N/A Other Buy 599 2,635.60 EUR
2024-02-28 N/A Other Buy 1,600 6,720.00 EUR
2024-02-26 N/A Other Buy 500 2,150.00 EUR
2024-02-22 N/A Other Buy 500 2,250.00 EUR
2024-02-20 N/A Other Other 1,000 4,800.00 EUR

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC